Promis Neurosciences Stock Technical Analysis
| PMN Stock | USD 1.03 0.07 7.29% |
As of the 23rd of November, ProMIS Neurosciences holds the Risk Adjusted Performance of (0.02), coefficient of variation of (2,366), and Variance of 20.75. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ProMIS Neurosciences, as well as the relationship between them.
ProMIS Neurosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ProMIS, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ProMISProMIS |
ProMIS Neurosciences Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 0.5 | Strong Buy | 2 | Odds |
Most ProMIS analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ProMIS stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ProMIS Neurosciences, talking to its executives and customers, or listening to ProMIS conference calls.
ProMIS Neurosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ProMIS Neurosciences Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ProMIS Neurosciences volatility. High ATR values indicate high volatility, and low values indicate low volatility.
ProMIS Neurosciences Trend Analysis
Use this graph to draw trend lines for ProMIS Neurosciences. You can use it to identify possible trend reversals for ProMIS Neurosciences as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual ProMIS Neurosciences price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.ProMIS Neurosciences Best Fit Change Line
The following chart estimates an ordinary least squares regression model for ProMIS Neurosciences applied against its price change over selected period. The best fit line has a slop of 0.0062 , which may imply that the returns on investment in ProMIS Neurosciences will continue to fail. It has 122 observation points and a regression sum of squares at 1.44, which is the sum of squared deviations for the predicted ProMIS Neurosciences price change compared to its average price change.About ProMIS Neurosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ProMIS Neurosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ProMIS Neurosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ProMIS Neurosciences price pattern first instead of the macroeconomic environment surrounding ProMIS Neurosciences. By analyzing ProMIS Neurosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ProMIS Neurosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ProMIS Neurosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Net Current Asset Value | 583.44 | 518.62 | Days Payables Outstanding | 363.15 | 381.3 |
ProMIS Neurosciences November 23, 2024 Technical Indicators
Most technical analysis of ProMIS help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ProMIS from various momentum indicators to cycle indicators. When you analyze ProMIS charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (1.67) | |||
| Mean Deviation | 3.33 | |||
| Coefficient Of Variation | (2,366) | |||
| Standard Deviation | 4.56 | |||
| Variance | 20.75 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.92) | |||
| Treynor Ratio | (1.68) | |||
| Maximum Drawdown | 25.96 | |||
| Value At Risk | (6.36) | |||
| Potential Upside | 6.25 | |||
| Skewness | 0.8209 | |||
| Kurtosis | 2.28 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.04 | Revenue Per Share 0.001 | Return On Assets (4.81) | Return On Equity (10.99) |
The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.